ofa lawsuit semaglutide The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing Maker of the popular medications

The CIR (Cosmetic Ingredient Review) has concluded this ingredient to be safe as used in cosmetics and it has not shown to be a skin sensitizer in testing (unless you have a known rice allergy)

Br J Cancer 114(12):1352-1361, 2016

All four products can be taken together at the same time

I'd like to see the word 'entrepreneur' knocked off its pedestal

These are unwelcome side effects considering many midlife women struggle with lower libido due to perimenopause and menopause

Boxed warnings are intentionally cautious, flagging potential risks so prescribers and patients can make informed decisions even when human evidence is uncertain